BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gregory DJ, Vannier A, Duey AH, Roady TJ, Dzeng RK, Pavlovic MN, Chapin MH, Mukherjee S, Wilmot H, Chronos N, Charles RC, Ryan ET, LaRocque RC, Miller TE, Garcia-Beltran WF, Thierauf JC, Iafrate AJ, Mullenbrock S, Stump MD, Wetzel RK, Polakiewicz RD, Naranbhai V, Poznansky MC. Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19. Virulence 2022;13:890-902. [PMID: 35587156 DOI: 10.1080/21505594.2022.2073025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Rak A, Gorbunov N, Kostevich V, Sokolov A, Prokopenko P, Rudenko L, Isakova-Sivak I. Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model. Viruses 2023;15. [PMID: 36680269 DOI: 10.3390/v15010230] [Reference Citation Analysis]
2 Delgado JF, Vidal-pla M, Moya MC, Espasa M, Casabella A, Seda M, Calvet J, Gratacós J, Serrano RM, Peña P, Xu B. SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection. Journal of Immunology Research 2022;2022:1-4. [DOI: 10.1155/2022/8287087] [Reference Citation Analysis]
3 Mullin S, Wyk BV, Asher JL, Compton SR, Allore HG, Zeiss CJ. Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data. PNAS Nexus 2022;1:pgac096. [PMID: 35799833 DOI: 10.1093/pnasnexus/pgac096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Sarah Mullin, Brent Vander Wyk, Jennifer L Asher, Susan R Compton, Heather G Allore, Caroline J Zeiss. Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data. PNAS Nexus 2022;1:pgac096. [PMID: 35799833 DOI: 10.1093/pnasnexus/pgac096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Harrison N, Richardson L, Pallini C, Morano I, Jinks E, Cowley J, Chan H, Hill HJ, de las Heras CM, Teodosio A, Lavado AS, Dafforn TR, Grammatopoulos DK, Gordon J, Brady CA, Young LS, Barnes NM, Stamataki Z, Qureshi OS. A cell-based, spike protein binding assay highlights differences in antibody neutralising capacity for SARS-CoV-2 variants.. [DOI: 10.1101/2022.06.24.496409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]